RAS (KRAS OR NRAS) GENE MUTATION
Clinical trials for RAS (KRAS OR NRAS) GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAS (KRAS OR NRAS) GENE MUTATION trials appear
Sign up with your email to follow new studies for RAS (KRAS OR NRAS) GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental pill targets Hard-to-Treat cancers in groundbreaking trial
Disease control Recruiting nowThis early-stage trial is testing a new oral medication called NST-628 for adults with advanced solid tumors that have specific genetic changes in a key cancer growth pathway. The study aims to find a safe and effective dose and see if the drug can shrink tumors in patients who h…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Massive canadian cancer study hunts clues in rare genes
Knowledge-focused Recruiting nowThis study aims to gather real-world information from 5,500 Canadian adults with cancer who have uncommon genetic changes in their tumors. It will track their health journeys, treatments, and quality of life to understand how different therapies work for these specific genetic pr…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC